Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line.

[1]  S. Lory,et al.  Pseudomonas-epithelial cell interactions dissected with DNA microarrays. , 2002, Chest.

[2]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[3]  T. Flotte,et al.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  O. Eidelman,et al.  Control of the Proinflammatory State in Cystic Fibrosis Lung Epithelial Cells by Genes from the TNF-αR/NFκB Pathway , 2001, Molecular medicine.

[5]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[6]  M. Hodson,et al.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. , 2000, The European respiratory journal.

[7]  J. Christman,et al.  Exaggerated Activation of Nuclear Factor- κ B and Altered I κ B- β Processing in Cystic Fibrosis Bronchial Epithelial Cells , 2000 .

[8]  Roger E Bumgarner,et al.  Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Konstan,et al.  IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. , 1999, American journal of respiratory and critical care medicine.

[10]  O. Eidelman,et al.  Pharmacogenomics of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Cystic Fibrosis Drug CPX Using Genome Microarray Analysis , 1999, Molecular medicine.

[11]  A. Lentsch,et al.  Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. , 1999, The American journal of physiology.

[12]  G. Döring.  Serine proteinase inhibitor therapy in α1‐antitrypsin inhibitor deficiency and cystic fibrosis , 1999 .

[13]  M. Sockrider,et al.  The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. , 1999, Chest.

[14]  P. Sherwood Burge,et al.  Inhaled corticosteroids in COPD , 1999, Thorax.

[15]  M. Konstan.  Therapies aimed at airway inflammation in cystic fibrosis. , 1998, Clinics in chest medicine.

[16]  Michael A. Fiedler,et al.  Inhibition of TNF- α -induced NF- κ B Activation and IL-8 Release in A549 Cells with the Proteasome Inhibitor MG-132 , 1998 .

[17]  A J Ratner,et al.  Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. , 1998, The Journal of clinical investigation.

[18]  M. Konstan,et al.  Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. , 1997, The Journal of clinical investigation.

[19]  D. Corry,et al.  IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. , 1997, Journal of immunology.

[20]  N. Klein,et al.  Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis , 1997, Archives of disease in childhood.

[21]  G. Döring.  Anti‐inflammatory therapy , 1997, Pediatric pulmonology. Supplement.

[22]  M. Konstan.  Treatment of airway inflammation in cystic fibrosis. , 1996, Current opinion in pulmonary medicine.

[23]  M. Schöni,et al.  Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. , 1996, The Journal of pediatrics.

[24]  A. Prince,et al.  Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. , 1995, The Journal of clinical investigation.

[25]  K. Jacobson,et al.  A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. , 1995, Biochemistry.

[26]  K. Jacobson,et al.  CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells. , 1995, The American journal of physiology.

[27]  P. J. Byard,et al.  Effect of high-dose ibuprofen in patients with cystic fibrosis. , 1995, The New England journal of medicine.

[28]  A. Prince,et al.  Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Lammers,et al.  The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. , 1995, Respiratory medicine.

[30]  K. Matsushima,et al.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases , 1994, Infection and immunity.

[31]  T. Flotte,et al.  Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. , 1994, The American journal of physiology.

[32]  M. Drumm,et al.  Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. , 1993, The Journal of biological chemistry.

[33]  T. Flotte,et al.  Gene expression from adeno-associated virus vectors in airway epithelial cells. , 1992, American journal of respiratory cell and molecular biology.

[34]  T. Flotte,et al.  Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR , 1992, Nature.

[35]  C. Hoppel,et al.  Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. , 1991, The Journal of pediatrics.

[36]  R. Craig,et al.  A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. , 1991, American journal of respiratory cell and molecular biology.

[37]  R. Crystal,et al.  Aerosol α1 -antitrypsin treatment for cystic fibrosis , 1991, The Lancet.

[38]  W. Dougall,et al.  Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. , 1990, The Journal of biological chemistry.

[39]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[40]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[41]  D. Geddes,et al.  Anti-inflammatory gene therapy directed at the airway epithelium , 2000, Gene Therapy.

[42]  R. Dinwiddie,et al.  Role of corticosteroids in cystic fibrosis lung disease. , 1996, Journal of the Royal Society of Medicine.

[43]  V. Wahn,et al.  Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum. , 1995, Respiration; international review of thoracic diseases.

[44]  Research Paper Mediators of Inflammation, 8, 13–15 (1999) , 2022 .